isomethyleugenol has been researched along with Graft vs Host Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mavers, M | 1 |
| Chen, S; Feng, S; Feng, X; Guo, W; Han, M; He, Y; Huang, Y; Jiang, E; Liu, M; Liu, Y; Luo, Y; Ma, Q; Niu, Q; Pang, A; Pei, X; Su, X; Wang, Q; Wei, J; Yang, D; Zhai, W; Zhang, R | 1 |
| Anczurowski, M; Arrowsmith, CH; Butler, MO; Guo, T; Hirano, N; Kagoya, Y; Matsunaga, Y; Murata, K; Saijo, H; Saso, K; Sugata, K; Wang, CH | 1 |
| Alahmari, B; Choi, J; Cooper, M; DiPersio, JF; Ritchey, J; Ziga, E | 1 |
| Li, L; Rong, R; Wang, J; Xu, M; Zhu, T | 1 |
| Chinnaiyan, AM; He, S; King, PD; Lapinski, PE; Liu, Y; Mani, RS; Mineishi, S; Mochizuki, I; Mochizuki, K; Reddy, P; Tong, Q; Xie, F; Zhang, Y | 1 |
| Baron, F; Colau, D; Coulie, PG; Cuende, J; De Boeck, G; De Haard, H; Dedobbeleer, O; Delvenne, P; Dumoutier, L; Hannon, M; Huygens, C; Liénart, S; Lucas, S; Renauld, JC; Saunders, M; Somja, J; Stockis, J; van der Woning, B | 1 |
| Eriksson, M; Schmidt, A; Shang, MM; Tegnér, J; Weyd, H | 1 |
| Chen, P; Fung, H; Gu, Y; He, S; Hexner, E; Hu, S; Huang, J; Huang, Q; Jin, J; Jin, M; Li, C; Liu, Y; Ma, A; Reshef, R; Tian, Y; Tong, Q; Yu, H; Zhang, Y | 1 |
| Chinnaiyan, AM; He, S; Kato, K; Kuick, R; Liu, Y; Mani, RS; Marquez, VE; Mineishi, S; Mochizuki, K; Nieves, E; Varambally, S; Wang, J; Xie, F; Zhang, Y | 1 |
10 other study(ies) available for isomethyleugenol and Graft vs Host Disease
| Article | Year |
|---|---|
Inhibiting post-translational methylation to prevent GVHD.
Topics: Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methylation; Protein Processing, Post-Translational | 2023 |
Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation.
Topics: Adolescent; Adult; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Bone Marrow; Bone Marrow Transplantation; Child; Disease Models, Animal; Down-Regulation; Female; Forkhead Transcription Factors; Gene Deletion; Gene Expression Profiling; Graft vs Host Disease; Humans; Male; Methylation; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Protein Serine-Threonine Kinases; T-Lymphocytes, Regulatory; Transcription, Genetic | 2020 |
Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells.
Topics: Animals; Arginine; Biomarkers; Cell Line; Cytokines; Disease Models, Animal; Fluorescent Antibody Technique; Forkhead Transcription Factors; Gene Expression Profiling; Graft vs Host Disease; Humans; Kaplan-Meier Estimate; Male; Methylation; Mice; Mutation; Protein Processing, Post-Translational; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory | 2019 |
Selective targeting of histone modification fails to prevent graft versus host disease after hematopoietic cell transplantation.
Topics: Adenosine; Animals; Benzamides; Biphenyl Compounds; Cells, Cultured; Disease Models, Animal; Enhancer of Zeste Homolog 2 Protein; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histone Code; Histones; Humans; Indoles; Methylation; Mice; Morpholines; Pyridones; T-Lymphocytes | 2018 |
Modulation of allogeneic CD8+ T-cell response by DZNep controls GVHD while preserving hematopoietic chimerism.
Topics: Adenosine; Animals; Apoptosis; Cell Proliferation; Disease Models, Animal; Enzyme Inhibitors; Fas Ligand Protein; Female; Graft vs Host Disease; Granzymes; Hematopoietic Stem Cell Transplantation; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Lymphocyte Activation; Male; Methylation; Mice; Mice, Inbred C3H; T-Lymphocytes, Cytotoxic; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Transplantation Chimera; Transplantation Tolerance; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 2013 |
The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease.
Topics: Allografts; Animals; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Bone Marrow Transplantation; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Graft vs Host Disease; Membrane Proteins; Methylation; Mice; Mice, Inbred BALB C; Mice, Knockout; Polycomb Repressive Complex 2; Proto-Oncogene Proteins; STAT4 Transcription Factor; T-Box Domain Proteins; T-Lymphocytes | 2013 |
Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo.
Topics: Animals; Antibodies, Monoclonal; Autoimmunity; Epitopes; Graft vs Host Disease; Humans; Immunosuppressive Agents; Membrane Proteins; Methylation; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Protein Binding; Protein Conformation; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1 | 2015 |
Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate.
Topics: Animals; Butyrates; Female; Forkhead Transcription Factors; Graft vs Host Disease; Humans; Interferon-gamma; Interleukin-10; Interleukin-17; Interleukin-2; Lymphocyte Activation; Methylation; Mice, Inbred NOD; Sirolimus; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Tretinoin | 2016 |
Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice.
Topics: Animals; Enhancer of Zeste Homolog 2 Protein; Graft vs Host Disease; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Histones; HSP90 Heat-Shock Proteins; Indoles; Isoxazoles; Lysine; Methylation; Mice, Inbred BALB C; Mice, Inbred C57BL; Minor Histocompatibility Antigens; Protein Domains; Protein Stability; Pyridones; Resorcinols; T-Lymphocytes; Transplantation, Homologous | 2017 |
Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells.
Topics: Adenosine; Animals; Apoptosis; Cells, Cultured; Disease Progression; Enzyme Inhibitors; Graft vs Host Disease; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Isoantigens; Lymphocyte Activation; Methylation; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Substrate Specificity; T-Lymphocytes; Up-Regulation | 2012 |